Abstract
Here, we report a case of long-term survival after resection of an adenocarcinoma in Barrett’s esophagus with metastasis to Virchow’s node. A 71-year-old women was referred to our hospital with a tumor in the lower third of the thoracic esophagus, located just beneath the tracheal bifurcation because of an hiatal hernia. On admission, she had a palpable lymph node in Virchow’s node. The esophageal tumor and this lymph node were biopsied. They were pathologically found to be an adenocarcinoma in the esophagus which had metastasised to the lymph node. She underwent transthoracic esophagectomy with three-field lymph node dissection. The pathological diagnosis was adenocarcinoma in Barrett’s esophagus with the UICC stage classification of pT1, pN1, pM1-LYM, Stage IVB. She received postoperative chemotherapy of cisplatin combined with 5-fluorouracil. The patient is well without recurrence at 14 years to date after surgery. We recommend thoracoabdominal esophagectomy with three-field lymphadenectomy for an advanced carcinoma in the upper and middle thoracic esophagus regardless of histological types.
Similar content being viewed by others
References
Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232: 353–61.
Fujita H, Sueyoshi S, Tanaka T, Fujii T, Toh U, Mine T, et al. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: Comparing the short-and long-term outcome among the four types of lymphadenectomy. World J Surg 2003; 27: 571–9.
Fujita H, Sueyoshi S, Tanaka T, Shirouzu K. Threefield dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg 2002; 8: 328–35.
Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett’s cancer. World J Surg 2003; 27: 1052–7.
Heroor A, Fujita H, Sueyoshi S, Tanaka T, Toh U, Mine T, et al. Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: Who benefits? A retrospective study. Dig Surg 2003; 20: 229–37.
Fujita H, Kakegawa T, Yamana H, Shima I, Tanaka H, Ikeda S, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg 1994; 18: 266–72.
Holscher AH, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845–55.
Tachimori Y, Kato H, Watanabe H. Surgery for thoracic esophageal carcinoma with clinically positive cervical nodes. J Thorac Cardiovasc Surg 1998; 116: 954–9.
Sato T. Regional Anatomy for Gastroenterological Surgery: Esophagus and stomach. Tokyo: Kanehara & Co. Ltd., 1993: 57–98.
Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study— JCOG 9204. J Clin Oncol 2003; 21: 4592–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matono, S., Fujita, H., Sueyoshi, S. et al. Long-term survival after three-field lymph-adenectomy for an adenocarcinoma in Barrett’s esophagus with metastasis to Virchow’s node. Jpn J Thorac Caridovasc Surg 54, 11–15 (2006). https://doi.org/10.1007/BF02743777
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02743777